Product Images Polymyxin B

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Polymyxin B NDC 0143-9461 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - polymyxin b for injection usp 1

Chemical Structure - polymyxin b for injection usp 1

This text appears to mention the sequence of amino acids (Dab, Phe, Leu, Thr) in the structure of Polymyxin B. It also indicates a structural difference between two variations of Polymyxin B molecule (R=CH3 and R=H). The text seems to be related to a chemical or pharmaceutical study of Polymyxin B variants.*

unit label - polymyxin b for injection usp 2

unit label - polymyxin b for injection usp 2

This is a description of Polymyxin B for Injection, USP, with a concentration of 500,000 units per vial. The drug is intended for hospital use and is administered via intramuscular, intravenous, or intrathecal routes. The packaging includes a warning about potential neuro-toxicity and nephrotoxicity. It is manufactured by Hikma Pharmaceuticals USA, Inc. in Berkeley Heights, NJ. Each vial contains Polymyxin B Sulfate equivalent to 500,000 Polymyxin B units. The recommended storage conditions are specified before and after reconstitution. After reconstitution, the product must be stored under refrigeration and any unused portion should be discarded after 72 hours.*

carton 10 - polymyxin b for injection usp 3

carton 10 - polymyxin b for injection usp 3

This text provides information about the dosage, warning, administration, and storage instructions for a drug containing Polymyxin B, which is used for neuro- and nephrotoxic conditions. It emphasizes that the drug should be administered intramuscularly, intravenously, or intrathecally in hospitalized patients only. The storage requirements include refrigeration after reconstitution. The drug is manufactured by Hikma Pharmaceuticals USA and is recommended for hospital use only. Each vial contains Polymyxin B Sulfate equivalent to 500,000 polymyxin B units, and any unused portion should be discarded after 72 hours.*

carton 01 - polymyxin b for injection usp 4

carton 01 - polymyxin b for injection usp 4

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.